Polarean Imaging (PLLWF) Price & Analysis

Compare

6 Followers

PLLWF Stock Chart & Stats

$0.01

<$0.01(33.33%)

At close: Jan 08 4:00 PM EST

$0.01

<$0.01(33.33%)

Day’s Range― - ―

52-Week Range$0.01 - $0.02

Previous CloseN/A

Volume15.00K

Average Volume (3M)0.00

Market Cap

$1.61M

Enterprise Value$11.91M

Total Cash (Recent Filing)$7.29M

Total Debt (Recent Filing)$441.66K

Price to Earnings (P/E)―

Beta-1.63

Next Earnings

Jun 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,207,032,800

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)1.03

Price to Sales (P/S)5.15

P/FCF Ratio-2.88

Enterprise Value/Market Cap7.38

Enterprise Value/Revenue6.00

Enterprise Value/Gross Profit36.68

Enterprise Value/Ebitda-1.74

Forecast

1Y Price Target

$0.05

Price Target Upside400.00% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market ExpansionPolarean has signed a distribution agreement with Sumtage Enterprise for the distribution of Polarean’s Xenon MRI platform in Taiwan, marking Polarean's entry into the Taiwanese market.

Strategic CollaborationPolarean has signed a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the US.

Bears Say

Commercial Roll-OutA potential commercial roll-out in Taiwan seems unlikely until the second half of 2026.

Polarean Imaging News

Polarean Imaging’s XENOVIEW 3T coil passes Philips compatibility testing

Polarean Imaging (PLLWF) announces that its FDA-cleared XENOVIEW 3T Chest Coil has completed compatibility testing conducted by Philips...

19d ago

Polarean Imaging signs exclusive distribution agreement with DK Healthcare

Polarean Imaging (PLLWF) signed an exclusive distribution agreement with DK Healthcare for the distribution of Polarean’s Xenon MRI...

26d ago

Polarean Imaging to Delist from AIM and Re-register as Private Company

Polarean Imaging ( ($GB:POLX) ) has provided an announcement. Polarean Imaging PLC announced that all resolutions were passed...

5d ago

Polarean Imaging’s XENOVIEW® 3T Coil Achieves Philips Compatibility, Expanding Clinical Reach

The latest announcement is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging has announced that its FDA-cleared...

20d ago

Polarean Imaging Expands into Asia with Xenon MRI Installation in Taiwan

Polarean Imaging ( ($GB:POLX) ) has shared an update. Polarean Imaging has announced its first installation of a...

26d ago

Polarean Imaging Expands into South Korea with DK Healthcare Partnership

An update from Polarean Imaging ( ($GB:POLX) ) is now available. Polarean Imaging plc has entered into an...

27d ago

Polarean Imaging to Go Private, Aiming for Strategic Flexibility

An announcement from Polarean Imaging ( ($GB:POLX) ) is now available. Polarean Imaging PLC has announced its intention...

1M ago

Polarean Imaging PLC Explores Strategic Options Amid Market Challenges

The latest update is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging PLC is conducting a strategic...

2M ago

Polarean Imaging Plc’s Earnings Call: Mixed Sentiment Amid Growth and Challenges

Polarean Imaging Plc (($GB:POLX)) has held its Q2 earnings call. Read on for the main highlights of the...

2M ago

Polarean Imaging Expands US Market Reach with Ascend Imaging Partnership

The latest update is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging has expanded its agreement with...

3M ago

Polarean Imaging Partners with UVA Health for Clinical Xenon MRI Expansion

Polarean Imaging ( ($GB:POLX) ) just unveiled an announcement. Polarean Imaging has entered into a new supply agreement...

3M ago

Polarean Imaging Sells Xenon MRI System to NIH Clinical Center

The latest announcement is out from Polarean Imaging ( ($GB:POLX) ). Polarean Imaging has announced the sale of...

3M ago

Polarean Imaging announces FDA expansion of XENOVIEW indication

Polarean Imaging (PLLWF) announces that the US Food and Drug Administration has approved the Company’s Supplemental New Drug...

7M ago

Polarean Imaging says Xenon MRI to be featured prominently at ATS 2025

Polarean Imaging (PLLWF) will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit, taking place...

7M ago

PLLWF FAQ

What was Polarean Imaging Plc’s price range in the past 12 months?

Polarean Imaging Plc lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.

What is Polarean Imaging Plc’s market cap?

Polarean Imaging Plc’s market cap is $1.61M.

When is Polarean Imaging Plc’s upcoming earnings report date?

Polarean Imaging Plc’s upcoming earnings report date is Jun 18, 2026 which is in 180 days.

How were Polarean Imaging Plc’s earnings last quarter?

Polarean Imaging Plc released its earnings results on Sep 25, 2025. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.

Is Polarean Imaging Plc overvalued?

According to Wall Street analysts Polarean Imaging Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Polarean Imaging Plc pay dividends?

Polarean Imaging Plc does not currently pay dividends.

What is Polarean Imaging Plc’s EPS estimate?

Polarean Imaging Plc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Polarean Imaging Plc have?

Polarean Imaging Plc has 1,207,032,800 shares outstanding.

What happened to Polarean Imaging Plc’s price movement after its last earnings report?

Polarean Imaging Plc reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Polarean Imaging Plc?

Currently, no hedge funds are holding shares in PLLWF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Polarean Imaging Plc

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

Polarean Imaging (PLLWF) Earnings & Revenues

Historic Earnings Reports

PLLWF Stock 12 Month Forecast

Average Price Target

$0.05

▲(400.00% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","-1":"-$1","-0.25":"-$0.25","0.5":"$0.5","1.25":"$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.05</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2021","6":"Jul<br/>2024","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.01,0.013076923076923076,0.016153846153846154,0.019230769230769232,0.022307692307692306,0.025384615384615387,0.02846153846153846,0.031538461538461536,0.03461538461538462,0.03769230769230769,0.04076923076923077,0.04384615384615385,0.04692307692307692,{"y":0.05,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.01,0.013076923076923076,0.016153846153846154,0.019230769230769232,0.022307692307692306,0.025384615384615387,0.02846153846153846,0.031538461538461536,0.03461538461538462,0.03769230769230769,0.04076923076923077,0.04384615384615385,0.04692307692307692,{"y":0.05,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.01,0.013076923076923076,0.016153846153846154,0.019230769230769232,0.022307692307692306,0.025384615384615387,0.02846153846153846,0.031538461538461536,0.03461538461538462,0.03769230769230769,0.04076923076923077,0.04384615384615385,0.04692307692307692,{"y":0.05,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.19,"date":1614556800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.19,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.19,"date":1619827200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.19,"date":1619827200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1669852800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.04,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.04,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.01,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.01,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.01,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >